IL10 and colitis: Treatment with rSj-Cys significantly reduced TNBS-induced experimental colitis in mice through upregulation of Treg cells and related cytokines IL-10 and TGF-β, and downregulation of pro-inflammatory cytokines TNF-α and IL-6 in the colon tissues of mice [44].